Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
2002 3
2003 1
2004 1
2006 3
2007 2
2009 2
2010 7
2011 6
2012 6
2013 6
2014 6
2015 13
2016 8
2017 5
2018 5
2019 6
2020 4
2021 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
Krop IE, Masuda N, Mukohara T, Takahashi S, Nakayama T, Inoue K, Iwata H, Yamamoto Y, Alvarez RH, Toyama T, Takahashi M, Osaki A, Saji S, Sagara Y, O'Shaughnessy J, Ohwada S, Koyama K, Inoue T, Li L, Patel P, Mostillo J, Tanaka Y, Sternberg DW, Sellami D, Yonemori K. Krop IE, et al. Among authors: alvarez rh. J Clin Oncol. 2023 Dec 20;41(36):5550-5560. doi: 10.1200/JCO.23.00882. Epub 2023 Oct 6. J Clin Oncol. 2023. PMID: 37801674 Free PMC article. Clinical Trial.
Ixabepilone for the treatment of breast cancer.
Alvarez RH, Valero V, Hortobagyi GN. Alvarez RH, et al. Ann Med. 2011;43(6):477-86. doi: 10.3109/07853890.2011.579151. Epub 2011 May 17. Ann Med. 2011. PMID: 21585248 Review.
Bevacizumab treatment for advanced breast cancer.
Alvarez RH, Guarneri V, Icli F, Johnston S, Khayat D, Loibl S, Martin M, Zielinski C, Conte P, Hortobagyi GN. Alvarez RH, et al. Oncologist. 2011;16(12):1684-97. doi: 10.1634/theoncologist.2011-0113. Epub 2011 Oct 5. Oncologist. 2011. PMID: 21976315 Free PMC article. Review.
Emerging targeted therapies for breast cancer.
Alvarez RH, Valero V, Hortobagyi GN. Alvarez RH, et al. J Clin Oncol. 2010 Jul 10;28(20):3366-79. doi: 10.1200/JCO.2009.25.4011. Epub 2010 Jun 7. J Clin Oncol. 2010. PMID: 20530283 Review.
Investigational strategies in chronic myelogenous leukemia.
Cortes JE, O'Brien SM, Giles F, Alvarez RH, Talpaz M, Kantarjian HM. Cortes JE, et al. Among authors: alvarez rh. Hematol Oncol Clin North Am. 2004 Jun;18(3):619-39, ix. doi: 10.1016/j.hoc.2004.03.004. Hematol Oncol Clin North Am. 2004. PMID: 15271396 Review.
Inflammatory breast cancer: what we know and what we need to learn.
Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, Iwamoto T, Krishnamurthy S, Yang W, Reuben JM, Hortobágyi GN, Ueno NT. Yamauchi H, et al. Among authors: alvarez rh. Oncologist. 2012;17(7):891-9. doi: 10.1634/theoncologist.2012-0039. Epub 2012 May 14. Oncologist. 2012. PMID: 22584436 Free PMC article. Review.
85 results